BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 8302820)

  • 1. Scanning electron microscopic distinction of pleural mesotheliomas from adenocarcinomas.
    Jandik WR; Landas SK; Bray CK; Lager DJ
    Mod Pathol; 1993 Nov; 6(6):761-4. PubMed ID: 8302820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant mesothelioma: ultrastructural distinction from adenocarcinoma.
    Warhol MJ; Hickey WF; Corson JM
    Am J Surg Pathol; 1982 Jun; 6(4):307-14. PubMed ID: 6287872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of electron microscopy in the diagnosis of diffuse mesotheliomas using human pleural effusions.
    Butler EB; Johnson NF
    IARC Sci Publ; 1980; (30):409-18. PubMed ID: 7239661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The distinction of mesothelioma from adenocarcinoma in malignant effusions by electron microscopy.
    Kobzik L; Antman KH; Warhol MJ
    Acta Cytol; 1985; 29(3):219-25. PubMed ID: 3859121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pleural mesothelioma of epithelial type and pulmonary adenocarcinoma: an ultrastructural and cytochemical comparison.
    Dewar A; Valente M; Ring NP; Corrin B
    J Pathol; 1987 Aug; 152(4):309-16. PubMed ID: 3668733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of ThinPrep and cytospin preparation in pleural effusion cytological diagnosis of mesothelioma and adenocarcinoma.
    Ylagan LR; Zhai J
    Diagn Cytopathol; 2005 Mar; 32(3):137-44. PubMed ID: 15690333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant mesotheliomas. Improved differential diagnosis from lung adenocarcinomas using monoclonal antibodies 44-3A6 and 624A12.
    Lee I; Radosevich JA; Chejfec G; Ma YX; Warren WH; Rosen ST; Gould VE
    Am J Pathol; 1986 Jun; 123(3):497-507. PubMed ID: 3717302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinctive microvillous brush border staining with HBME-1 distinguishes pleural mesotheliomas from pulmonary adenocarcinomas.
    Dahlstrom JE; Maxwell LE; Brodie N; Zardawi IM; Jain S
    Pathology; 2001 Aug; 33(3):287-91. PubMed ID: 11523926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparing electron microscopical investigation of cells from mesotheliomas (author's transl)].
    Jaugitz H
    Arch Geschwulstforsch; 1977; 47(3):204-9. PubMed ID: 907441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of analytical SEM in the determination of causation in malignant mesothelioma.
    Roggli VL
    Ultrastruct Pathol; 2006; 30(1):31-5. PubMed ID: 16517468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scope of scanning electron microscopy, transmission electron microscopy and freeze fracture technique in diagnostic cytology of effusions.
    Mukherjee TM; Smith K; Swift JG
    Scan Electron Microsc; 1983; (Pt 3):1317-27. PubMed ID: 6648341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ultrastructural pathology of malignant pleural mesothelioma.
    Coleman M; Henderson DW; Mukherjee TM
    Pathol Annu; 1989; 24 Pt 1():303-53. PubMed ID: 2654842
    [No Abstract]   [Full Text] [Related]  

  • 13. Diagnostic efficacy of electron microscopy and pleural effusion cytology for the distinction of pleural mesothelioma and lung adenocarcinoma.
    Domínguez-Malagón H; Cano-Valdez AM; González-Carrillo C; Campos-Salgado YE; Lara-Garcia A; Lopez-Mejia M; Corona-Cruz JF; Arrieta O
    Ultrastruct Pathol; 2016; 40(5):254-60. PubMed ID: 27405014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrastructure of pleural mesothelioma and pulmonary adenocarcinoma in malignant effusions as compared with reactive mesothelial cells.
    Sakuma N; Kamei T; Ishihara T
    Acta Cytol; 1999; 43(5):777-85. PubMed ID: 10518130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative ultrastructural study of nuclei from exfoliated benign and malignant mesothelial cells and metastatic adenocarcinoma cells.
    Dardick I; Butler EB; Dardick AM
    Acta Cytol; 1986; 30(4):379-84. PubMed ID: 3461648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ultrastructure of asbestos-induced mesotheliomas].
    Topov Ia; Kolev K
    Vopr Onkol; 1985; 31(4):75-8. PubMed ID: 4002674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of membranous staining of mesothelioma.
    King JA; Tucker JA
    Cell Vis; 1998; 5(1):24-7. PubMed ID: 9660721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical evaluation of pleural mesothelioma and pulmonary adenocarcinoma. A bi-institutional study of 47 cases.
    Otis CN; Carter D; Cole S; Battifora H
    Am J Surg Pathol; 1987 Jun; 11(6):445-56. PubMed ID: 2438954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A scanning electron microscopic study of diffuse mesothelioma and some lung carcinomas.
    Dionne GP; Wang NS
    Cancer; 1977 Aug; 40(2):707-15. PubMed ID: 196741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calretinin, thrombomodulin, CEA, and CD15: a useful combination of immunohistochemical markers for differentiating pleural epithelial mesothelioma from peripheral pulmonary adenocarcinoma.
    Comin CE; Novelli L; Boddi V; Paglierani M; Dini S
    Hum Pathol; 2001 May; 32(5):529-36. PubMed ID: 11381372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.